CAS 52789-62-5|1-amino-8-naphthol-2,4-disulfonic acid monosodium salt

Introduction:Basic information about CAS 52789-62-5|1-amino-8-naphthol-2,4-disulfonic acid monosodium salt, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common Name1-amino-8-naphthol-2,4-disulfonic acid monosodium salt
CAS Number52789-62-5Molecular Weight341.29
Density1.477 g/mL at 25 °C(lit.)Boiling Point270-272 °C(lit.)
Molecular FormulaC10H8NNaO7S2Melting Point12-16 °C(lit.)
MSDS/Flash Point>230 °F

Names

Name1-Amino-8-naphthol-2,4-disulfonic Acid Monosodium Salt Hydrate
SynonymMore Synonyms

BiologicalActivity

DescriptionCaMKP inhibitor sodium is a selective inhibitor of ROCK1 with an IC50 value of 14 nM.
Related CatalogResearch Areas >>CancerSignaling Pathways >>Cell Cycle/DNA Damage >>ROCKSignaling Pathways >>Stem Cell/Wnt >>ROCKSignaling Pathways >>TGF-beta/Smad >>ROCK
Target

IC50: 14 nM (ROCK1)[1].

In VitroCaMKP inhibitor sodium at 1 μM reduces ROCK2 activity over 20-fold, under conditions in which the only other kinase tested that is significantly inhibited is MSK1 whose activity is reduced ~5-fold. CaMKP inhibitor sodium is a more selective ROCK2 inhibitor than the widely utilized ROCK inhibitor Y-27632 as assessed on kinase-specificity panel, and does not significantly inhibit LRRK2 even at doses as high as 30 μM (500-fold higher than IC50 of inhibition of ROCK2). CaMKP inhibitor sodium slightly inhibits RSK and p70S6K with IC50 of 0.78 μM and 1.94 μM, respectively. CaMKP inhibitor sodium significantly inhibits rat aortic ring dilation with IC50 of 190 nM[2].
In VivoCaMKP inhibitor sodium has 61% oral bioavailability in male Sprague-Dawley rats. Oral administration of CaMKP inhibitor sodium at single doses of 3-30 mg/kg dramatically reduces mean arterial pressure in the spontaneously hypertensive rats (SHRs) in a dose-dependent manner, with a maximum decrease of 50 mmHg after approximately 2 hours treatment at dose of 30 mg/kg[1].
References

[1]. Goodman KB et al Development of dihydropyridone indazole amides as selective Rho-kinase inhibitors. J Med Chem. 2007 Jan 11;50(1):6-9.  

[2]. Nichols RJ et al Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease. Biochem J. 2009 Oct 23;424(1):47-60.  

Chemical & Physical Properties

Density1.477 g/mL at 25 °C(lit.)
Boiling Point270-272 °C(lit.)
Melting Point12-16 °C(lit.)
Molecular FormulaC10H8NNaO7S2
Molecular Weight341.29
Flash Point>230 °F
Exact Mass340.96400
PSA174.58000
LogP3.02120
Index of Refractionn20/D 1.498(lit.)
InChIKeyCFHHFSZBVRLYLD-UHFFFAOYSA-M
SMILESNc1c(S(=O)(=O)[O-])cc(S(=O)(=O)O)c2cccc(O)c12.O.O.[Na+]

Safety Information

Safety PhrasesS22-S24/25
HS Code2922199090

Customs

HS Code2922199090
Summary2922199090. other amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Synonyms

1-AMINO-8-NAPHTHOL-2,4-DISULFONIC ACID MONOSODIUM SALT
MFCD00068275
Chicago Acid Hydrate
SS Acid Hydrate
Sodium Hydrogen 4-Amino-5-hydroxy-1,3-naphthalenedisulfonate Hydrate
Monosodium 1-Amino-8-naphthol-2,4-disulfonate Hydrate
EINECS 258-185-0
4-Amino-5-hydroxy-1,3-naphthalenedisulfonic Acid Monosodium Salt Hydrate
2S Acid Hydrate
CAS 449210-08-6|1-methyl-2,4-dioxo-1H,2H,3H,4H-pyrido[2,3-d]pyrimidine-6-carboxylic acid
CAS 141-72-0|Butane,1,1'-[(1-methylethylidene)bis(oxy)]bis-
Recommended......
TOP